Bio-Techne Corp ROE 2006-2018 | TECH

Current and historical return on equity (ROE) values for Bio-Techne Corp (TECH) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Bio-Techne Corp ROE for the three months ending September 30, 2018 was 14.09%.
Bio-Techne Corp ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2018-09-30 $0.13B $1.11B 12.06%
2018-06-30 $0.13B $1.08B 12.41%
2018-03-31 $0.11B $1.06B 11.40%
2017-12-31 $0.12B $1.00B 12.05%
2017-09-30 $0.07B $0.96B 7.87%
2017-06-30 $0.08B $0.95B 8.34%
2017-03-31 $0.07B $0.91B 8.28%
2016-12-31 $0.08B $0.89B 9.32%
2016-09-30 $0.10B $0.90B 11.60%
2016-06-30 $0.11B $0.88B 12.26%
2016-03-31 $0.11B $0.85B 12.37%
2015-12-31 $0.10B $0.86B 11.78%
2015-09-30 $0.11B $0.84B 12.75%
2015-06-30 $0.11B $0.85B 13.04%
2015-03-31 $0.11B $0.82B 13.38%
2014-12-31 $0.12B $0.82B 14.56%
2014-09-30 $0.11B $0.79B 13.87%
2014-06-30 $0.11B $0.80B 14.57%
2014-03-31 $0.11B $0.78B 14.98%
2013-12-31 $0.11B $0.75B 15.41%
2013-09-30 $0.11B $0.73B 15.69%
2013-06-30 $0.11B $0.74B 15.81%
2013-03-31 $0.11B $0.72B 16.03%
2012-12-31 $0.11B $0.70B 16.33%
2012-09-30 $0.11B $0.68B 17.10%
2012-06-30 $0.11B $0.67B 18.04%
2012-03-31 $0.11B $0.64B 18.87%
2011-12-31 $0.11B $0.60B 19.32%
2011-09-30 $0.11B $0.59B 19.97%
2011-06-30 $0.11B $0.59B 20.20%
2011-03-31 $0.11B $0.57B 20.62%
2010-12-31 $0.11B $0.54B 21.45%
2010-09-30 $0.11B $0.52B 21.62%
2010-06-30 $0.11B $0.50B 22.40%
2010-03-31 $0.11B $0.50B 22.73%
2009-12-31 $0.11B $0.49B 22.79%
2009-09-30 $0.10B $0.47B 23.45%
2009-06-30 $0.11B $0.46B 23.67%
2009-03-31 $0.11B $0.43B 23.71%
2008-12-31 $0.11B $0.42B 23.62%
2008-09-30 $0.11B $0.49B 23.02%
2008-06-30 $0.10B $0.49B 22.02%
2008-03-31 $0.10B $0.47B 21.74%
2007-12-31 $0.09B $0.47B 21.09%
2007-09-30 $0.09B $0.47B 20.94%
2007-06-30 $0.09B $0.44B 21.55%
2007-03-31 $0.08B $0.41B 21.90%
2006-12-31 $0.08B $0.39B 22.24%
2006-09-30 $0.08B $0.36B 23.35%
2006-06-30 $0.07B $0.34B 23.68%
2006-03-31 $0.07B $0.32B 25.15%
2005-12-31 $0.07B $0.28B 26.03%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.181B $0.643B
Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits; and clinical diagnostic immunoassay kits. The Company also offers flow cytometry products; natural and synthetic chemical compounds; hematology controls and calibrators; and hematology control products. Bio-Techne Corporation, formerly known as Techne Corporation, is headquartered in Minneapolis, Minnesota.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $122.066B 13.80
Gilead Sciences (GILD) United States $91.187B 10.98
Biogen (BIIB) United States $64.253B 13.01
Celgene (CELG) United States $49.661B 9.64
Illumina (ILMN) United States $45.627B 53.15
Vertex Pharmaceuticals (VRTX) United States $44.173B 77.17
Regeneron Pharmaceuticals (REGN) United States $37.448B 19.00
Alexion Pharmaceuticals (ALXN) United States $26.459B 18.11
BioMarin Pharmaceutical (BMRN) United States $16.572B 0.00
Incyte (INCY) United States $13.377B 369.77
Seattle Genetics (SGEN) United States $8.805B 0.00
Exact Sciences (EXAS) United States $8.388B 0.00
Sarepta Therapeutics (SRPT) United States $8.074B 0.00
Bio-Rad Laboratories (BIO.B) United States $8.015B 51.25
QIAGEN (QGEN) Netherlands $8.006B 25.61
Alnylam Pharmaceuticals (ALNY) United States $6.862B 0.00
Bluebird Bio (BLUE) United States $6.541B 0.00
BeiGene (BGNE) Cayman Islands $5.950B 0.00
Amarin (AMRN) Ireland $5.794B 0.00
Alkermes (ALKS) Ireland $5.392B 3470.00
Galapagos (GLPG) Belgium $5.218B 0.00
Exelixis (EXEL) United States $4.763B 13.50
Immunomedics (IMMU) United States $3.890B 0.00
Horizon Pharma Public (HZNP) Ireland $3.644B 14.99
MorphoSys AG Unsponsored ADR (MOR) Germany $3.535B 0.00
Emergent Biosolutions (EBS) United States $3.347B 28.19
Ligand Pharmaceuticals (LGND) United States $3.281B 25.28
Guardant Health (GH) United States $3.269B 0.00
Array BioPharma (ARRY) United States $3.217B 0.00
Allogene Therapeutics (ALLO) United States $3.113B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.988B 0.00
ARGENX SE-ADR (ARGX) Netherlands $2.981B 0.00
Repligen (RGEN) United States $2.864B 89.44
Genomic Health (GHDX) United States $2.855B 97.10
Blueprint Medicines (BPMC) United States $2.624B 0.00
Ascendis Pharma (ASND) Denmark $2.532B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.483B 0.00
Acceleron Pharma (XLRN) United States $2.385B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.359B 0.00
Allakos (ALLK) United States $2.351B 0.00
Akcea Therapeutics (AKCA) United States $2.327B 0.00
China Biologic Products (CBPO) China $2.321B 16.52
MyoKardia (MYOK) United States $2.255B 0.00
REGENXBIO (RGNX) United States $2.248B 30.15
Myriad Genetics (MYGN) United States $2.217B 21.97
Halozyme Therapeutics (HALO) United States $2.183B 48.71
Global Blood Therapeutics (GBT) United States $2.018B 0.00
Amicus Therapeutics (FOLD) United States $1.914B 0.00
AnaptysBio (ANAB) United States $1.889B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.877B 0.00
Reata Pharmaceuticals (RETA) United States $1.865B 0.00
Arena Pharmaceuticals (ARNA) United States $1.683B 0.00
Medicines (MDCO) United States $1.650B 0.00
Aimmune Therapeutics (AIMT) United States $1.642B 0.00
Cambrex (CBM) United States $1.636B 12.22
Innoviva (INVA) United States $1.631B 9.22
G1 THERAPEUTICS (GTHX) United States $1.609B 0.00
Denali Therapeutics (DNLI) United States $1.583B 0.00
Spark Therapeutics (ONCE) United States $1.572B 0.00
NeoGenomics (NEO) United States $1.547B 127.92
Atara Biotherapeutics (ATRA) United States $1.542B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.463B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $1.377B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.363B 0.00
Editas Medicine (EDIT) United States $1.348B 0.00
IMMURON LTD (IMRN) Australia $1.294B 0.00
Mirati Therapeutics (MRTX) United States $1.249B 0.00
Myovant Sciences (MYOV) United Kingdom $1.247B 0.00
Insmed (INSM) United States $1.237B 0.00
ORCHARD THERAPT (ORTX) United Kingdom $1.219B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.186B 94.25
Rubius Therapeutics (RUBY) United States $1.164B 0.00
WAVE Life Sciences (WVE) Singapore $1.163B 0.00
Cellectis (CLLS) France $1.073B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.033B 0.00
Solid Biosciences (SLDB) United States $1.024B 0.00
Retrophin (RTRX) United States $1.022B 0.00
Sangamo Therapeutics (SGMO) United States $1.017B 0.00
DBV Technologies (DBVT) France $1.010B 0.00
Audentes Therapeutics (BOLD) United States $1.007B 0.00
Intra-Cellular Therapies (ITCI) United States $0.977B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.955B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.940B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.905B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.903B 0.00
Lion Biotechnologies (IOVA) United States $0.897B 0.00
UniQure (QURE) Netherlands $0.894B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.888B 0.00
Acorda Therapeutics (ACOR) United States $0.875B 11.08
Aptinyx (APTX) United States $0.856B 0.00
Puma Biotechnology (PBYI) United States $0.844B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.841B 0.00
Fate Therapeutics (FATE) United States $0.839B 0.00
Viking Therapeutics (VKTX) United States $0.838B 0.00
Revance Therapeutics (RVNC) United States $0.837B 0.00
Apellis Pharmaceuticals (APLS) United States $0.828B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.789B 0.00
Athenex (ATNX) United States $0.778B 0.00
Clovis Oncology (CLVS) United States $0.763B 0.00
Dynavax Technologies (DVAX) United States $0.763B 0.00
Heska (HSKA) United States $0.762B 62.36
Intellia Therapeutics (NTLA) United States $0.751B 0.00
Coherus BioSciences (CHRS) United States $0.745B 0.00
Cara Therapeutics (CARA) United States $0.743B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.717B 0.00
InflaRx (IFRX) Germany $0.710B 0.00
Vericel (VCEL) United States $0.695B 0.00
AVROBIO (AVRO) United States $0.678B 0.00
Novavax (NVAX) United States $0.655B 0.00
UROGEN PHARMA (URGN) Israel $0.628B 0.00
CytomX Therapeutics (CTMX) United States $0.622B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.621B 0.00
ANI Pharmaceuticals (ANIP) United States $0.621B 11.90
Inotek Pharmaceuticals (RCKT) United States $0.612B 0.00
Gritstone Oncology (GRTS) United States $0.601B 0.00
TWIST BIOSCIENC (TWST) $0.599B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.597B 0.00
Epizyme (EPZM) United States $0.593B 0.00
Senesco Technologies (ELOX) United States $0.590B 0.00
Scholar Rock Holding (SRRK) United States $0.585B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.574B 0.00
Principia Biopharma (PRNB) United States $0.573B 0.00
AC Immune SA (ACIU) Switzerland $0.570B 0.00
ObsEva SA (OBSV) Switzerland $0.541B 0.00
Eidos Therapeutics (EIDX) United States $0.537B 0.00
Arcus Biosciences (RCUS) United States $0.533B 0.00
Arvinas (ARVN) United States $0.523B 0.00
Mesoblast (MESO) Australia $0.516B 0.00
UNITY Biotechnology (UBX) $0.508B 0.00
Anika Therapeutics (ANIK) United States $0.505B 20.91
Kezar Life Sciences (KZR) United States $0.500B 0.00
BeyondSpring (BYSI) United States $0.462B 0.00
Prothena (PRTA) Ireland $0.453B 0.00
Inovio Pharmaceuticals (INO) United States $0.450B 0.00
Replimune (REPL) United States $0.448B 0.00
Kindred Biosciences (KIN) United States $0.436B 0.00
Kura Oncology (KURA) United States $0.436B 0.00
Sinovac Biotech (SVA) China $0.434B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.430B 0.00
Zymeworks (ZYME) Canada $0.429B 0.00
PDL BioPharma (PDLI) United States $0.415B 6.76
Sorrento Therapeutics (SRNE) United States $0.407B 69.80
MediciNova (MNOV) United States $0.400B 0.00
Five Prime Therapeutics (FPRX) United States $0.398B 0.00
Stemline Therapeutics (STML) United States $0.391B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.377B 0.00
RA PHARMCTL INC (RARX) United States $0.375B 0.00
Verastem (VSTM) United States $0.375B 0.00
Abeona Therapeutics (ABEO) United States $0.370B 0.00
Zealand Pharma (ZEAL) Denmark $0.369B 0.00
Cytokineticsorporated (CYTK) United States $0.362B 0.00
Osiris Therapeutics (OSIR) United States $0.361B 0.00
MeiraGTx Holdings (MGTX) United States $0.354B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.332B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.330B 0.00
Seres Therapeutics (MCRB) United States $0.327B 0.00
ResTORbio (TORC) United States $0.317B 0.00
Merus (MRUS) Netherlands $0.313B 0.00
Krystal Biotech (KRYS) United States $0.312B 0.00
Sutro Biopharma (STRO) United States $0.310B 0.00
Cellular Biomedicine (CBMG) United States $0.307B 0.00
LogicBio Therapeutics (LOGC) United States $0.301B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.296B 0.00
MannKind (MNKD) United States $0.294B 0.00
Kodiak Sciences (KOD) United States $0.293B 0.00
Geron (GERN) United States $0.293B 0.00
Albireo Pharma (ALBO) United States $0.292B 0.00
Liquidia Technologies (LQDA) United States $0.289B 0.00
Aduro Biotech (ADRO) United States $0.284B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.284B 0.00
Celcuity (CELC) United States $0.281B 0.00
Kadmon Holdings (KDMN) United States $0.277B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.277B 0.00
Celyad SA (CYAD) Belgium $0.275B 0.00
Athersys (ATHX) United States $0.269B 0.00
Equillium (EQ) United States $0.261B 0.00
Magenta Therapeutics (MGTA) United States $0.261B 0.00
BioDelivery Sciences (BDSI) United States $0.258B 0.00
Syros Pharmaceuticals (SYRS) United States $0.252B 0.00
Arbutus Biopharma (ABUS) Canada $0.246B 0.00
Strongbridge Biopharma (SBBP) United States $0.245B 0.00
Evelo Biosciences (EVLO) United States $0.244B 0.00
GAMIDA CELL LTD (GMDA) $0.243B 0.00
Proteostasis Therapeutics (PTI) United States $0.242B 0.00
ADMA Biologics Inc (ADMA) United States $0.239B 0.00
Axovant Sciences (AXON) United Kingdom $0.238B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.238B 0.00
Urovant Sciences (UROV) United States $0.235B 0.00
Adverum Biotechnologies (ADVM) United States $0.233B 0.00
TOCAGEN INC (TOCA) United States $0.232B 0.00
Agenus (AGEN) United States $0.230B 0.00
Protagonist Therapeutics (PTGX) United States $0.227B 0.00
Kamada (KMDA) Israel $0.223B 20.56
Corvus Pharmaceuticals (CRVS) United States $0.220B 0.00
Kala Pharmaceuticals (KALA) United States $0.219B 0.00
Idera Pharmaceuticals (IDRA) United States $0.216B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.214B 0.00
BioTime (BTX) United States $0.213B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.210B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.206B 0.00
Unum Therapeutics (UMRX) United States $0.203B 0.00
Synlogic (SYBX) United States $0.197B 0.00
Intec Pharma (NTEC) Israel $0.193B 0.00
ChromaDex (CDXC) United States $0.190B 0.00
NantKwest (NK) United States $0.187B 0.00
Palatin Technologies (PTN) United States $0.187B 7.71
ASLAN Pharmaceuticals (ASLN) Singapore $0.179B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.178B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.172B 0.00
Cerecor (CERC) United States $0.163B 16.67
Compugen (CGEN) Israel $0.161B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.161B 0.00
Menlo Therapeutics (MNLO) United States $0.160B 0.00
PSivida (EYPT) United States $0.160B 0.00
Allena Pharmaceuticals (ALNA) United States $0.159B 0.00
Cohbar (CWBR) United States $0.159B 0.00
Pfenex (PFNX) United States $0.159B 0.00
Spero Therapeutics (SPRO) United States $0.154B 0.00
Enzo Biochem (ENZ) United States $0.151B 0.00
Constellation Pharmaceuticals (CNST) United States $0.146B 0.00
XBiotech (XBIT) United States $0.144B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.143B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.138B 0.00
Pluristem Therapeutics (PSTI) Israel $0.135B 0.00
Mersana Therapeutics (MRSN) United States $0.135B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.134B 0.00
Eleven Biotherapeutics (SESN) United States $0.133B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.130B 0.00
Organovo Holdings (ONVO) United States $0.129B 0.00
Applied Genetic Technologies (AGTC) United States $0.128B 0.00
Catalyst Biosciences (CBIO) United States $0.128B 0.00
Mustang Bio (MBIO) United States $0.125B 0.00
Cue Biopharma (CUE) United States $0.123B 0.00
VBI Vaccines (VBIV) United States $0.123B 0.00
CorMedix Inc (CRMD) United States $0.122B 0.00
Selecta Biosciences (SELB) United States $0.121B 0.00
XOMA (XOMA) United States $0.120B 0.00
OVID THERAPEUTC (OVID) United States $0.117B 0.00
Anavex Life Sciences (AVXL) United States $0.114B 0.00
PHASEBIO PHARMA (PHAS) United States $0.113B 0.00
Cidara Therapeutics (CDTX) United States $0.113B 0.00
Signal Genetics (MGEN) United States $0.112B 0.00
Motif Bio Plc (MTFB) United States $0.110B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.106B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.098B 0.00
Chiasma (CHMA) United States $0.097B 0.00
Provention Bio (PRVB) United States $0.096B 0.00
ScPharmaceuticals (SCPH) United States $0.094B 0.00
Orgenesis (ORGS) United States $0.092B 0.00
Monster Digital (INNT) United States $0.091B 0.00
Ophthotech (OPHT) United States $0.089B 0.00
VolitionRX (VNRX) Singapore $0.089B 0.00
Neothetics (EVFM) United States $0.088B 0.00
BioXcel Therapeutics (BTAI) United States $0.087B 0.00
Axsome Therapeutics (AXSM) United States $0.087B 0.00
VTv Therapeutics (VTVT) United States $0.083B 0.00
Prima BioMed (IMMP) Australia $0.081B 0.00
Cel-Sci (CVM) United States $0.079B 0.00
Aptose Biosciences (APTO) Canada $0.078B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.076B 0.00
Alcobra (ARCT) United States $0.074B 0.00
Aptevo Therapeutics (APVO) United States $0.074B 0.00
NewLink Genetics (NLNK) United States $0.074B 0.00
Checkpoint Therapeutics (CKPT) United States $0.073B 0.00
Vaccinex (VCNX) United States $0.071B 0.00
Evogene (EVGN) Israel $0.070B 0.00
Alimera Sciences (ALIM) United States $0.070B 0.00
Bionano Genomics (BNGO) United States $0.070B 0.00
Asterias Biotherapeutics (AST) United States $0.070B 0.00
ITUS (ANIX) United States $0.068B 0.00
Oncobiologics (ONS) United States $0.064B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.063B 0.00
Protalix BioTherapeutics (PLX) Israel $0.062B 0.00
VistaGen Therapeutics (VTGN) United States $0.061B 0.00
Cocrystal Pharma (COCP) United States $0.061B 68.33
Entera Bio (ENTX) Israel $0.060B 0.00
Sophiris Bio (SPHS) United States $0.059B 0.00
Bellerophon Therapeutics (BLPH) United States $0.059B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.059B 0.00
Leap Therapeutics (LPTX) United States $0.058B 0.00
Celldex Therapeutics (CLDX) United States $0.058B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.057B 9.25
Fortress Biotech (FBIO) United States $0.057B 0.00
Clearside Biomedical (CLSD) United States $0.055B 0.00
Trevena (TRVN) United States $0.055B 0.00
OncoSec Medical (ONCS) United States $0.051B 0.00
Caladrius Biosciences (CLBS) United States $0.050B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.048B 0.00
Curis (CRIS) United States $0.048B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.046B 0.00
Vascular Biogenics (VBLT) Israel $0.046B 0.00
Zosano Pharma (ZSAN) United States $0.045B 0.00
Oncolytics Biotech (ONCY) Canada $0.045B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.043B 0.00
TRACON Pharmaceuticals (TCON) United States $0.041B 0.00
Galena Biopharma (SLS) United States $0.041B 0.00
AquaBounty Technologies (AQB) United States $0.040B 0.00
AEterna Zentaris (AEZS) United States $0.040B 7.53
Versartis (ARAV) United States $0.039B 6.39
BiondVax Pharmaceuticals (BVXV) Israel $0.039B 0.00
AZURRX BIOPHARM (AZRX) United States $0.038B 0.00
Celsion (CLSN) United States $0.038B 0.00
VIVUS (VVUS) United States $0.036B 0.00
GTx (GTXI) United States $0.036B 0.00
Moleculin Biotech (MBRX) United States $0.036B 0.00
BioPharmX (BPMX) United States $0.034B 0.00
Proteon Therapeutics (PRTO) United States $0.034B 0.00
Eyenovia (EYEN) United States $0.031B 0.00
Advaxis (ADXS) United States $0.028B 0.00
Therapix Biosciences (TRPX) Israel $0.027B 10.21
Vical (VICL) United States $0.027B 0.00
Aileron Therapeutics (ALRN) United States $0.027B 0.00
Novelion Therapeutics (NVLN) Canada $0.026B 0.00
OvaScience (OVAS) United States $0.026B 0.00
Benitec Biopharma (BNTC) Australia $0.026B 0.00
Cellect Biotechnology (APOP) Israel $0.025B 0.00
CytRx (CYTR) United States $0.024B 0.00
GENPREX INC (GNPX) United States $0.023B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.022B 0.00
Edge Therapeutics (EDGE) United States $0.021B 0.00
Pulmatrix (PULM) United States $0.019B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Arsanis (ASNS) United States $0.019B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
ATyr Pharma (LIFE) United States $0.018B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
TrovaGene (TROV) United States $0.018B 0.00
Gemphire Therapeutics (GEMP) United States $0.017B 0.00
RestorGenex (DFFN) United States $0.017B 0.00
Soligenix (SNGX) United States $0.017B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.014B 0.00
Histogenics (HSGX) United States $0.014B 0.00
IBio (IBIO) United States $0.014B 0.00
Vital Therapies (VTL) United States $0.014B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Oragenics (OGEN) United States $0.011B 0.00
Cerulean Pharma (DARE) United States $0.010B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
ARCA Biopharma (ABIO) United States $0.010B 0.00
AmpliPhi Biosciences (APHB) United States $0.010B 0.00
Adial Pharmaceuticals (ADIL) United States $0.009B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Alliqua BioMedical (ALQA) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.008B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
Neuralstem (CUR) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Synthetic Biologics (SYN) United States $0.006B 0.00
Tenax Therapeutics (TENX) United States $0.006B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00
OSMOTICA PHARM (OSMT) United States $0.000B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.000B 0.00